ODENSE, October 5th, 2022 – Ossiform, We Print Bone™, is pleased to announce that it has completed a £6 million capital raise through West Hill Capital. Ossiform has developed a disruptive and patented technology to produce and supply P3D Bone; 3D printed patient-specific, resorbable bone implants that remodel into real living bone. Positive testing results toward FDA clearance have been obtained, and sales of Ossiform’s 3D printed R&D products for enhancing bone and cancer research, the P3D Scaffolds, have been established internationally.